Key facts
- Medical AI’s last known valuation is $39.5M (Jul 2025).
- It has raised $13.4M; the latest was Later Stage VC ($5.8M) in Jul 2025.
- Notable investors include IMM Investment, Bass Investment, New Paradigm Investment, Bodyfriend, Withwin Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Medical AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Medical AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medical AI
Developer of a health consultation platform designed for everyday health management. The company's platform evaluates health status through electrocardiograms and builds a log of health maintenance activities, enabling healthcare professionals to determine if they need an expert reading and confirm the final reading result through identity verification, ensuring secure data transmission and management.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2019
- Employees
- 15
- Website
- medicalai.com/
- Ownership
- Privately Held (backing)
Medical AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medical AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medical AI in its N-PORT filings yet. We sweep new filings monthly.